GlassScriptPhysician profile
David M Adams
NPI 1669695920
$4,036.78
in general payments reported to CMS, 2019-2025
12 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2021: $85.77 · 2022: $370 · 2023: $373 · 2024: $1,081 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713 · Travel and Lodging: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.63 |
| Travel and Lodging | $1,222.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,201.14 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $1,089.00 | 2019-2025 | Lithovue, General - Pain Management, Lithoclast |
| Valencia Technologies Corporation | $705.17 | 2024-2025 | Ecoin Device Kit |
| Medtronic, INC. | $376.06 | 2021-2025 | Interstim, Aquamantys(Tm) |
| Astellas Pharma US INC | $223.42 | 2019 | |
| Medtronic USA, INC. | $112.93 | 2019 | |
| Abbvie INC. | $108.44 | 2019 | |
| Laborie Medical Technologies Corp. | $98.61 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Acacia Pharma INC | $66.67 | 2022 | |
| Merck Sharp & Dohme LLC | $34.28 | 2019-2022 | |
| Karl Storz Endoscopy-America | $12.77 | 2023 | Flex-X |
| Ambu INC. | $8.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$300,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.